D-Glucitol, 1,4:3,6-dianhydro-2,5-di-O-ethenyl CAS 40268-97-1

D-Glucitol, 1,4:3,6-dianhydro-2,5-di-O-ethenyl (CAS 40268-97-1) Ultimate Guide

Contents

• 1. Product Specifications & Comparative Analysis
• 2. Industrial Applications & Functional Mechanisms
• 3. Operational Protocols & Implementation Scenarios
• 4. Verified Client Success Stories
• 5. Technical Consultation & Procurement Guidance

1. Product Specifications & Comparative Analysis

2. Industrial Applications & Functional Mechanisms

This bicyclic ether derivative demonstrates exceptional performance in:

• Pharmaceutical intermediates for antidiabetic drug synthesis
• Cross-linking agent in specialty polymer production
• Chiral resolving agent in asymmetric catalysis
• Surfactant precursor for high-purity detergents

3. Operational Protocols & Implementation Scenarios

Pharmaceutical Manufacturing Process

Optimal reaction conditions: 40-60°C in anhydrous DMF with 1.2:1 molar ratio to substrate. Achieves 92% yield in stepwise nucleophilic substitutions.

Polymer Modification Procedure

0.5-2.0% additive concentration increases glass transition temperature (Tg) by 15-20°C in polyether matrices.

4. Verified Client Success Stories

Case Study 1: European Pharma Innovator

Challenge: Required stable chiral intermediate for GLP-1 analog production
Solution: Implemented CAS 40268-97-1 in multi-step synthesis
Outcome: 30% yield improvement vs. previous intermediates

Case Study 2: Asian Polymer Specialist

Challenge: Needed high-temperature resistant adhesives
Solution: 1.8% additive incorporation
Outcome: Achieved 260°C thermal resistance (UL94 V-0 rating)

5. Technical Consultation & Procurement Guidance

For customized specifications or bulk pricing:
Email: info@vivalr.com
Tel: (86) 15866781826

Procurement Checklist

• Confirm required purity grade (Standard/Pharma/Custom)
• Specify packaging requirements (1kg/5kg/25kg)
• Request COA/MSDS documentation